Skip to main content
Germany
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
  • Aidian – Your aid in diagnostics
  • Produkte
  • Über uns
  • Nachrichten
  • Antimikrobielle Resistenz
  • Aidian Academy
  • Expertengespräche
  • Events
  • Apotheken
Kontakt Produkte bestellen Suche
Logo
Kontakt
  • Patientennahe Sofortdiagnostik (POCT)
  • Hygieneüberwachung
  • Mikrobiologie
  • Molecular Dx - microbiology
  • RIA / Kollagene
  • Atemwegsinfektionen
Patientennahe Sofortdiagnostik (POCT)
  • QuikRead go
Weiterlesen
QuikRead go
  • QuikRead go Instrument
  • QuikRead go Plus Instrument
  • QuikRead go CRP
  • QuikRead go easy CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go Zubehör
QuikRead go
Hygieneüberwachung
  • Easicult
  • Hygicult
  • Clean Card PRO
Weiterlesen
Mikrobiologie
  • Uricult Vet
  • Uricult
  • Meridian Immunoassays
  • Meridian Curian®
Weiterlesen
Molecular Dx - microbiology
  • Meridian Revogene®
  • Meridian Alethia®
Weiterlesen
RIA / Kollagene
  • UniQ
Weiterlesen
  • Aidian in Deutschland
  • Vorstand und Management
  • Unternehmenskultur
  • Nachhaltigkeit
  • Karriere
  • Nachrichten
  • Produktnachrichten
  • AMR
  • Veranstaltungen
  • Stories from customers
  • COVID-19
  • Über das C-reaktive Protein (CRP)
  • CRP und Infektionen der unteren Atemwege
  • Weiterführende Informationen
  • QuikRead go CRP-Produkte
  • Verbreitung antibiotikaresistenter Bakterien
  • Nützliche Links
  • Generally
  • Product information
  • Courses
  • Documents and materials
  • Frequently asked questions
  • CRP-Messungen bei Frühchen
  • POC-Tests im Praxisalltag
  • Schlafhygiene: Kontrolle der Sauberkeit von Kissen und Bettbezügen
  • Die Rheuma Bustour
  • POC Testungen in der Apotheke
  • Ein Plus an Service für Ihre Apotheke
  • Was ist ein CRP-Test und wie kann er Ihnen helfen?
  • Was ist ein HbA1c-Test und wie kann er Ihnen helfen?
  • Was ist ein Strep A-Test und wie kann er Ihnen helfen?
Logo
Kontakt Schließen
  • Produkte
    • Patientennahe Sofortdiagnostik (POCT)
      • QuikRead go
    • Hygieneüberwachung
      • Easicult
      • Hygicult
      • Clean Card PRO
    • Mikrobiologie
      • Uricult Vet
      • Uricult
      • Meridian Immunoassays
      • Meridian Curian®
    • Molecular Dx - microbiology
      • Meridian Revogene®
      • Meridian Alethia®
    • RIA / Kollagene
      • UniQ
    • Atemwegsinfektionen
  • Über uns
    • Aidian in Deutschland
    • Vorstand und Management
    • Unternehmenskultur
    • Nachhaltigkeit
    • Karriere
  • Nachrichten
    • Nachrichten
    • Produktnachrichten
    • AMR
    • Veranstaltungen
    • Stories from customers
    • COVID-19
  • Antimikrobielle Resistenz
    • Über das C-reaktive Protein (CRP)
    • CRP und Infektionen der unteren Atemwege
    • Weiterführende Informationen
    • QuikRead go CRP-Produkte
    • Verbreitung antibiotikaresistenter Bakterien
    • Nützliche Links
  • Aidian Academy
    • Generally
    • Product information
    • Courses
    • Documents and materials
    • Frequently asked questions
  • Expertengespräche
    • CRP-Messungen bei Frühchen
    • POC-Tests im Praxisalltag
    • Schlafhygiene: Kontrolle der Sauberkeit von Kissen und Bettbezügen
    • Die Rheuma Bustour
  • Events
  • Apotheken
    • POC Testungen in der Apotheke
    • Ein Plus an Service für Ihre Apotheke
    • Was ist ein CRP-Test und wie kann er Ihnen helfen?
    • Was ist ein HbA1c-Test und wie kann er Ihnen helfen?
    • Was ist ein Strep A-Test und wie kann er Ihnen helfen?
Beliebte Produkte
QuikRead go CRP+Hb

QuikRead go CRP+Hb

QuikRead go Plus Instrument

QuikRead go Plus Instrument

Uricult-Tests

Uricult-Tests

Neuesten Nachrichten
Alle ansehen

Sanova präsentiert den QuikRead go Plus auf dem Pädiatrischen Frühling in Seggau

15. Mai 2025 | Nachrichten, Produktnachrichten

Treffen Sie uns auf dem 32. Bayerischen Hausärztetag in Erlangen

9. Mai 2025 | Nachrichten, Veranstaltungen

Leben retten: Reinigen Sie Ihre Hände

5. Mai 2025 | Nachrichten, Produktnachrichten

  • Alle ansehen
  • keine Ergebnisse gefunden
  • Loading...
Nachrichten

Sanova präsentiert den QuikRead go Plus auf dem Pädiatrischen Frühling in Seggau

15. Mai 2025 | Nachrichten, Produktnachrichten

Treffen Sie uns auf dem 32. Bayerischen Hausärztetag in Erlangen

9. Mai 2025 | Nachrichten, Veranstaltungen

Produkte bestellen
Zurück zu allen Nachrichten
6. Juni 2023
Nachrichten,
Produktnachrichten

Point of care CRP testing improves the patient care for family doctors

Rapid results, enhanced decision-making, and efficient patient management using QuikRead go®

Point of Care (POC) C-reactive protein (CRP) testing could transform the way family doctors diagnose and treat patients. CRP aids in the clinical management of patients with infections or inflammatory conditions. CRP production is proportional to the intensity of infection and inflammation. The short analysis time and a small sample volume of point of care CRP tests offer a substantial benefit compared to the laboratory CRP test. When used together with the clinical examination of a patient, QuikRead go CRP tests are excellent tools in the following situations:

  • differentiation of mild and severe infections
  • increasing diagnostic certainty and guiding appropriate antibiotic prescribing in acute infections1,2
  • evaluation, monitoring, and prediction of the infection course, inflammation and treatment response3-5
  • ruling out severe bacterial infection6
QuikRead go easy CRP


With the POC CRP testing approach, family doctors can now experience a multitude of benefits, that help in primary care:

  1. Rapid results: POC CRP testing provides family doctors with immediate access to patients’ CRP levels, allowing them to make timely and informed decisions. Within 2 minutes, doctors can obtain accurate CRP measurements using QuikRead go system, aiding in the diagnosis, and monitoring of various conditions, including infections and inflammatory diseases.1-6
  2. Enhanced decision-making: With immediate CRP results, family doctors can make more precise and evidence-based decisions regarding treatment plans. POC CRP testing enables doctors to determine the severity of infections, guide antibiotic prescribing practices, and identify patients who may require further investigations or secondary care referrals.7
  3. Targeted antibiotic prescribing: Overprescribing of antibiotics has become a global concern, contributing to antimicrobial resistance (AMR). POC CRP testing empowers family doctors to differentiate between mild and severe infections more effectively. By measuring CRP levels, physicians can identify patients who truly require antibiotics, reducing unnecessary prescriptions, and promoting responsible use of antibiotics.2,3
  4. Streamlined patient management: POC CRP testing facilitates efficient patient management within primary care settings. A quick and reliable on-site result reduces the patient’s waiting time and, at the same time, also the need for nursing resources for monitoring patients. Doctors can utilize CRP measurements to assess treatment response, monitor disease progression, and adjust medication dosages accordingly. This streamlined approach leads to improved patient outcomes and optimized resource utilization.8
  5. Cost-effectiveness: Integrating POC CRP testing into family practice can result in cost savings. By utilizing targeted antibiotic prescribing and minimizing unnecessary investigations, such as imaging or specialist consultations, primary care can allocate resources more efficiently while providing cost-effective care to patients.9

With rapid results, enhanced decision-making capabilities, and streamlined patient management, family doctors can deliver more accurate and personalized care to their patients. This approach promotes evidence-based medicine, reduces healthcare costs, and contributes to the overall well-being of not only individuals and communities, but also has a global impact on the AMR development.

To learn more about QuikRead go system, come and visit Aidian at WONCA Europe 2023 in Brussels during 8–10 June 2023!


References:

  1. Markanday A. Acute Phase Reactants in Infections: Evidence-Based Review and a Guide for Clinicians. Open Forum Infect Dis 2015; 2(3): ofv098.
  2. Little P et al. Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 2013; 382(9899): 1175-1182.
  3. Tonkin-Crane SKG et al. Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews (Review). Cohcrane Database of Systematic Reviews 2017; 7(9): CD012252.
  4. Bruns AH et al. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Eur Respir J 2008; 32(3): 726-732.
  5. Verhagen DW et al. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008; 168(3): 302-307.
  6. Emery P. Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 2007; 27(9): 793-806.
  7. Aabenhus, R., Hansen, M. P., Saust, L. T., Bjerrum, L., & Gahrn-Hansen, B. (2014). Clinical indications for antibiotic use in Danish general practice: results from a nationwide electronic prescription database. Scandinavian Journal of Primary Health Care, 32(4), 234-241. doi: 10.3109/02813432.2014.986970
  8. Aabenhus, R., Jensen, J. U., Jorgensen, K. J., Hróbjartsson, A., & Bjerrum, L. (2014). Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database of Systematic Reviews, 11, CD010130. doi: 10.1002/14651858.CD010130.pub2
  9. Cals JW, Ament AJ, Hood K, et al. C-reactive protein point of care testing and physician communication skills training for lower respiratory tract infections in general practice: economic evaluation of a cluster randomized trial. J Eval Clin Pract. 2011;17(6):1059–1069.


Share
Facebook
Twitter
Email

Aidian Germany GmbH

Papenreye 65
22453 Hamburg


040 5725 7760


Anfragen
info@aidian.de


Verkauf
bestellung@aidian.de

Unternehmen
  • Über uns
  • Nachhaltigkeit
  • Karriere
  • Kontakten Sie uns
  • AGBs
Produkte
  • Patientennahe Sofortdiagnostik (POCT)
  • Hygieneüberwachung
  • Mikrobiologie
  • Molecular Dx - microbiology
  • RIA / Kollagene
  • Atemwegsinfektionen
Quicklinks
  • Aidian Academy
  • Aidian Connect
  • Impressum
Copyright © 2025 Aidian
  • Datenschutz-Bestimmungen
  • Datenschutzerklärung
  • Cookie-Richtlinie
  • Social Media Policy